相关实验视频

Updated: May 31, 2025

Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein

Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein

Published on: March 9, 2015

VX-770,C_act-A1和增加的细胞内cAMP对CFTR活动有明显的急性影响

Heidi J Nick¹, Sarah E Christeson¹, Preston E Bratcher^1,2

¹Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA.

International journal of molecular sciences

|January 25, 2025

概括

研究人员探索了不同的囊性纤维化跨膜导电性调节器 (CFTR) 激活器和增强器如何影响离子运输. 他们的发现表明,药物应用的顺序和细胞类型影响CFTR活动,为未来的调节器开发提供了洞察力.

科学领域:

离子通道生理学离子通道生理学
细胞和分子生物学是细胞和分子生物学.
呼吸系统药物呼吸系统药物

背景情况:

囊性纤维化跨膜导电调节器 (CFTR) 是一个关键的离子通道,其功能障碍导致囊性纤维化 (CF).
通过酸化 (激活) 和门变化 (增强) 来调节CFTR活动.
像福斯科林/IBMX这样的常见激活剂增加了细胞内cAMP,而Cact-A1和VX-770 (ivacaftor) 则提供了替代机制.

研究的目的:

研究CFTR激活剂 (Cact-A1,福斯科林/IBMX) 和增强剂 (VX-770) 对CFTR活性的影响.
在不同的细胞模型和实验条件下描述这些调节器的相对贡献.
探索cAMP独立的激活剂和强化剂如何影响CFTR介导的离子运输.

主要方法:

使用了初级人类鼻上皮细胞 (HNEC) 培养物和菲舍尔大鼠甲状腺 (FRT) 细胞表达功能性CFTR.
采用Ussing室分析来测量CFTR介导的离子传输.
研究了VX-770,Cact-A1和福斯科林/IBMX单独或组合对CFTR活性的影响.

主要成果:

CFTR调节器的有效性因服用顺序,化学/电梯度,基线CFTR功能和细胞模型而异.
细胞内cAMP的增加影响了CFTR以外的细胞功能,影响了化物运输.
激活器和增强器的组合提供了CFTR离子运输的详细特征.

结论:

小分子CFTR激活剂和强化剂可以战略性地组合在一起,以详细描述CFTR功能.
这些方法对于研究初级HNEC和工程细胞系中CFTR介导的离子运输是有价值的.
未来的研究可能会发现具有明显治疗影响的新型CFTR缺陷和调节器.

关键词:

在CFTR中,CFTR是最重要的.在CFTR调制器.这就是Cact-A1的原因.在VX-77070中使用.气道离子运输气道离子运输在CAMP中,我们可以使用cAMP.囊性纤维化症是什么伊瓦卡夫托尔 (伊瓦卡夫托尔) 是一个

更多相关视频

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

In Vitro Analysis of PDZ-dependent CFTR Macromolecular Signaling Complexes

In Vitro Analysis of PDZ-dependent CFTR Macromolecular Signaling Complexes

Published on: August 13, 2012

相关概念视频

GPCRs Regulate Adenylyl Cylase Activity

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...